| Literature DB >> 23073726 |
Abstract
The increased use of opioid pain medication has been mirrored by the increased misuse and abuse of these drugs. As part of a multidisciplinary approach to this epidemic, pharmaceutical companies, with the encouragement of the Food and Drug Administration, have increased the development of abuse-deterrent formulations. While all have the goal of treating pain while mitigating misuse and abuse, there are different technologies utilized to impart the abuse-deterrent properties. The goal of this paper is to review the basis of abuse-deterrent formulations, the different types and approaches of some of the abuse-deterrent products, and their current regulatory status in the USA.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23073726 PMCID: PMC3550267 DOI: 10.1007/s13181-012-0270-y
Source DB: PubMed Journal: J Med Toxicol ISSN: 1556-9039